Simplex Trading, LLC Jasper Therapeutics, Inc. Transaction History

Simplex Trading, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	BUY	$0.42 - $0.93 $10 - $24	26 New	26 $0
Q2 2023 Aug 04, 2023	BUY	$1.19 - $1.79 $1,099 - $1,653	924 New	924 $1,000
Q4 2022 Feb 02, 2023	SELL	$0.46 - $8.9 $460 - $8,900	-1,000 Reduced 99.7%	3 $0
Q3 2022 Nov 04, 2022	BUY	$0.08 - $22.6 $80 - $22,667	1,003 New	1,003 $0
Q1 2022 May 02, 2022	SELL	$2.96 - $8.01 $2,072 - $5,607	-700 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$7.21 - $16.42 $5,047 - $11,494	700 New	700 $5,000

5.63M

Ticker JSPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,073,300
Market Cap $843M
Description
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a techniqu...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.